Coastar Therapeutics, Inc

Early-stage company developing biological payload delivery technologies for cancer immunotherapy and gene therapies. Coastar’s proprietary technology is a novel human erythrocyte-derived cell membrane encapsulation system that has many advantages related to immune system recognition and clearance.